drug-eluting stent

(redirected from Drug coated stent)
Also found in: Wikipedia.

drug-eluting stent

Abbreviation: DES
A stent coated with medications that it releases into surrounding intimal cells. It is designed to keep the lumen of an artery from closing both by holding the artery open and by retarding the growth of the vascular endothelium into the stent. See: bare metal stent
See also: stent
References in periodicals archive ?
The XIENCE V drug coated stent is used to treat coronary artery disease by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlled manner to prevent the artery from becoming blocked again following a stent procedure.
Our Integrated Delivery System (IDS), coupled with a truly unique bioabsorbale drug coated stent, will provide a highly differentiated technology which addresses all segments of the global stent market and provides important new benefits to patients, physicians and payers alike.
plans for LEADERS FREE, the first large-scale study for BioFreedom (TM), the next-generation polymer-free drug coated stent (" DCS ");
Drug coated stent was kept in 10ml of PBS and incubated at 37[degrees]C temperature with 60([+ or -] 5) RPM by means of Orbital shaking incubator.
In the most recent study, researchers followed almost 2,400 heart attack patients for the two years after they had received either a bare-metal or a drug coated stent.
The XIENCE V drug coated stent is used to treat CAD by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlled manner over time to help prevent the artery from becoming blocked again following the stent procedure.
The hydroxyapatite and drug coated stent can be fine tuned to prevent restenosis and 'late stent thrombosis'.
The cells used for the evaluation was human umbilical vein endothelial cells (HUVEC) and the proliferation rate of these cells on drug coated stent was compared against an uncoated stent made of the same base material as measured by the tritiated thymidine uptake of cells grown on these devices for period of 72h.
Patient outcomes, in addition to drug coated stent performance, will be assessed by measuring Late Lumen Loss, in-stent and in-segment lumen loss measurements at six months following implantation.
The extraordinary profitability of their Cypher drug coated stent will be used to fuel pharmaceutical acquisitions.
Wall Street is expecting Boston Scientific's earnings to skyrocket with the introduction of BSX' drug coated stent.
Recently, new drug coated stent technology utilizing rapamycin has shown dramatic prevention of in-stent restenosis at 6-9 months in selected patients.